Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 360 items for :

  • medullary thyroid carcinoma x
  • Refine by access: All content x
Clear All
Margarida M Moura Unidade de Investigação em Patobiologia Molecular (UIPM), Serviço de Endocrinologia, Clínica Universitária de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 Lisboa, Portugal

Search for other papers by Margarida M Moura in
Google Scholar
PubMed Close
,
Branca M Cavaco Unidade de Investigação em Patobiologia Molecular (UIPM), Serviço de Endocrinologia, Clínica Universitária de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 Lisboa, Portugal

Search for other papers by Branca M Cavaco in
Google Scholar
PubMed Close
, and
Valeriano Leite Unidade de Investigação em Patobiologia Molecular (UIPM), Serviço de Endocrinologia, Clínica Universitária de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 Lisboa, Portugal
Unidade de Investigação em Patobiologia Molecular (UIPM), Serviço de Endocrinologia, Clínica Universitária de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 Lisboa, Portugal
Unidade de Investigação em Patobiologia Molecular (UIPM), Serviço de Endocrinologia, Clínica Universitária de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 Lisboa, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed Close

mutated (total mutated samples/total samples tested) for that particular tumor type. RAS mutations have also been detected in medullary thyroid carcinomas (MTCs), and this subject will be further discussed in section ‘ RAS mutations in MTC

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0070
Volume/Issue:
Volume 22: Issue 5
Free access
Pierpaolo Trimboli Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland
Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Pierpaolo Trimboli in
Google Scholar
PubMed Close
,
Ettore Seregni Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Ettore Seregni in
Google Scholar
PubMed Close
,
Giorgio Treglia Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Giorgio Treglia in
Google Scholar
PubMed Close
,
Maria Alevizaki Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Maria Alevizaki in
Google Scholar
PubMed Close
, and
Luca Giovanella Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Luca Giovanella in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) is a malignancy that originates from thyroid parafollicular C cells and accounts for about 5% of thyroid cancers ( Kloos et al . 2009 ). In the majority of cases (i.e., four out of every five), this

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0156
Volume/Issue:
Volume 22: Issue 3
Free access
Lucieli Ceolin Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil

Search for other papers by Lucieli Ceolin in
Google Scholar
PubMed Close
,
Marta Amaro da Silveira Duval Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil

Search for other papers by Marta Amaro da Silveira Duval in
Google Scholar
PubMed Close
,
Antônio Felippe Benini Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil

Search for other papers by Antônio Felippe Benini in
Google Scholar
PubMed Close
,
Carla Vaz Ferreira Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil

Search for other papers by Carla Vaz Ferreira in
Google Scholar
PubMed Close
, and
Ana Luiza Maia Thyroid Unit, Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brasil

Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) is a malignant tumor originating in parafollicular or C cells of the thyroid. The main secretory product of MTC is calcitonin, a specific and highly sensitive biomarker that is produced by normal

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-18-0574
Volume/Issue:
Volume 26: Issue 9
Free access
Anna Angelousi Unit of Endocrinology, First Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Anna Angelousi in
Google Scholar
PubMed Close
,
Aimee R Hayes Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK

Search for other papers by Aimee R Hayes in
Google Scholar
PubMed Close
,
Eleftherios Chatzellis Endocrinology Diabetes and Metabolism Department, 251 Hellenic Air Force and VA General Hospital, Athens, Greece

Search for other papers by Eleftherios Chatzellis in
Google Scholar
PubMed Close
,
Gregory A Kaltsas First Department of Propaedeutic Internal Medicine, Laiko Hospital, National & Kapodistrian University of Athens, Athens, Greece

Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed Close
, and
Ashley B Grossman Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK
Green Templeton College, University of Oxford, Oxford, UK
Centre for Endocrinology, Barts and the London School of Medicine, London, UK

Search for other papers by Ashley B Grossman in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) is a malignant neuroendocrine tumour originating from the parafollicular or C-cells of the thyroid, capable of secreting calcitonin and carcinoembryonic antigen (CEA) ( Ceolin et al. 2019 ). It

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-21-0368
Volume/Issue:
Volume 29: Issue 7
Open access
Libero Santarpia Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Libero Santarpia in
Google Scholar
PubMed Close
,
George A Calin Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by George A Calin in
Google Scholar
PubMed Close
,
Liana Adam Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Liana Adam in
Google Scholar
PubMed Close
,
Lei Ye Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Lei Ye in
Google Scholar
PubMed Close
,
Alfredo Fusco Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Alfredo Fusco in
Google Scholar
PubMed Close
,
Serena Giunti Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Serena Giunti in
Google Scholar
PubMed Close
,
Christina Thaller Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Christina Thaller in
Google Scholar
PubMed Close
,
Laura Paladini Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Laura Paladini in
Google Scholar
PubMed Close
,
Xinna Zhang Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Xinna Zhang in
Google Scholar
PubMed Close
,
Camilo Jimenez Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Camilo Jimenez in
Google Scholar
PubMed Close
,
Francesco Trimarchi Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Francesco Trimarchi in
Google Scholar
PubMed Close
,
Adel K El-Naggar Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Adel K El-Naggar in
Google Scholar
PubMed Close
, and
Robert F Gagel Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Departments of Endocrine Neoplasia and Hormonal Disorders, Experimental Therapeutics , Urology, Department of Oncology, Department of Pathology, Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Department of Oncology, Department of Gynecologic Oncology, Department of Endocrinology, Department of Pathology, Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Robert F Gagel in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) is a neuroendocrine tumour thought to originate from neural crest parafollicular C-cells. Approximately 25% of MTC cases occur in the context of autosomal dominant multiple endocrine neoplasia syndrome

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-13-0357
Volume/Issue:
Volume 20: Issue 6
Free access
Mahdi Fallah Division of Molecular Genetic Epidemiology, Center for Primary Health Care Research, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany

Search for other papers by Mahdi Fallah in
Google Scholar
PubMed Close
,
Kristina Sundquist Division of Molecular Genetic Epidemiology, Center for Primary Health Care Research, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany

Search for other papers by Kristina Sundquist in
Google Scholar
PubMed Close
, and
Kari Hemminki Division of Molecular Genetic Epidemiology, Center for Primary Health Care Research, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
Division of Molecular Genetic Epidemiology, Center for Primary Health Care Research, German Cancer Research Center, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany

Search for other papers by Kari Hemminki in
Google Scholar
PubMed Close

nuclear family ( Amundadottir et al . 2004 ). Medullary thyroid carcinoma (MTC) is the third most common thyroid neoplasm (3–10%) after papillary (50–80%) and follicular (10–40%) carcinomas ( Hundahl et al . 1998 , Boyle 2008 , Pacini et al . 2010

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-13-0021
Volume/Issue:
Volume 20: Issue 5
Free access
Eric Y Lian Division of Cancer Biology and Genetics, Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Eric Y Lian in
Google Scholar
PubMed Close
,
Sarah M Maritan Division of Cancer Biology and Genetics, Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Sarah M Maritan in
Google Scholar
PubMed Close
,
Jessica G Cockburn Division of Cancer Biology and Genetics, Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Jessica G Cockburn in
Google Scholar
PubMed Close
,
Katayoon Kasaian Michael Smith Genome Sciences Centre, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

Search for other papers by Katayoon Kasaian in
Google Scholar
PubMed Close
,
Mathieu J F Crupi Division of Cancer Biology and Genetics, Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Mathieu J F Crupi in
Google Scholar
PubMed Close
,
David Hurlbut Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by David Hurlbut in
Google Scholar
PubMed Close
,
Steven J M Jones Michael Smith Genome Sciences Centre, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Department of Medical Genetics, University of British Columbia, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

Search for other papers by Steven J M Jones in
Google Scholar
PubMed Close
,
Sam M Wiseman Department of Surgery, St Paul’s Hospital & University of British Columbia, Vancouver, British Columbia, Canada

Search for other papers by Sam M Wiseman in
Google Scholar
PubMed Close
, and
Lois M Mulligan Division of Cancer Biology and Genetics, Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Lois M Mulligan in
Google Scholar
PubMed Close

, Romei et al . 2016 ). Constitutive activation of RET by specific point mutations gives rise to medullary thyroid carcinoma (MTC), a tumour of thyroid C-cells, as part of the familial cancer syndrome multiple endocrine neoplasia 2 (MEN2), and also occur

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0393
Volume/Issue:
Volume 24: Issue 1
Free access
Huy Gia Vuong Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan

Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed Close
,
Toru Odate Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan

Search for other papers by Toru Odate in
Google Scholar
PubMed Close
,
Hanh T T Ngo Department of Pathology, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam

Search for other papers by Hanh T T Ngo in
Google Scholar
PubMed Close
,
Thong Quang Pham Department of Pathology, Cho Ray Hospital, Ho Chi Minh City, Vietnam

Search for other papers by Thong Quang Pham in
Google Scholar
PubMed Close
,
Thao T K Tran Faculty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam

Search for other papers by Thao T K Tran in
Google Scholar
PubMed Close
,
Kunio Mochizuki Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan

Search for other papers by Kunio Mochizuki in
Google Scholar
PubMed Close
,
Tadao Nakazawa Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan

Search for other papers by Tadao Nakazawa in
Google Scholar
PubMed Close
,
Ryohei Katoh Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan

Search for other papers by Ryohei Katoh in
Google Scholar
PubMed Close
, and
Tetsuo Kondo Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan

Search for other papers by Tetsuo Kondo in
Google Scholar
PubMed Close

clinicopathological features of sporadic MTCs are presented in Table 2 . Table 2 Associations of RET , RAS mutation and RET M918T mutation with the clinicopathological parameters of sporadic medullary thyroid carcinoma. Clinicopathological

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-18-0056
Volume/Issue:
Volume 25: Issue 6
Free access
Viktor Johanson
Search for other papers by Viktor Johanson in
Google Scholar
PubMed Close
,
Håkan Ahlman
Search for other papers by Håkan Ahlman in
Google Scholar
PubMed Close
,
Peter Bernhardt
Search for other papers by Peter Bernhardt in
Google Scholar
PubMed Close
,
Svante Jansson
Search for other papers by Svante Jansson in
Google Scholar
PubMed Close
,
Lars Kölby
Search for other papers by Lars Kölby in
Google Scholar
PubMed Close
,
Fredrik Persson
Search for other papers by Fredrik Persson in
Google Scholar
PubMed Close
,
Göran Stenman
Search for other papers by Göran Stenman in
Google Scholar
PubMed Close
,
Christina Swärd
Search for other papers by Christina Swärd in
Google Scholar
PubMed Close
,
Bo Wängberg
Search for other papers by Bo Wängberg in
Google Scholar
PubMed Close
,
Mats Stridsberg
Search for other papers by Mats Stridsberg in
Google Scholar
PubMed Close
, and
Ola Nilsson
Search for other papers by Ola Nilsson in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) accounts for 5–10% of all thyroid cancer. Most cases are sporadic but about 25% occur in patients with the multiple endocrine neoplasia type 2 (MEN2) syndrome ( Brauckhoff et al

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-06-0033
Volume/Issue:
Volume 14: Issue 2
Free access
Nabahet Ameur CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Nabahet Ameur in
Google Scholar
PubMed Close
,
Ludovic Lacroix CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit
CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Ludovic Lacroix in
Google Scholar
PubMed Close
,
Sophie Roucan CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Sophie Roucan in
Google Scholar
PubMed Close
,
Véronique Roux CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Véronique Roux in
Google Scholar
PubMed Close
,
Sophie Broutin CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Sophie Broutin in
Google Scholar
PubMed Close
,
Monique Talbot CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Monique Talbot in
Google Scholar
PubMed Close
,
Corinne Dupuy CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Corinne Dupuy in
Google Scholar
PubMed Close
,
Bernard Caillou CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Bernard Caillou in
Google Scholar
PubMed Close
,
Martin Schlumberger CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
, and
Jean-Michel Bidart CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit
CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit

Search for other papers by Jean-Michel Bidart in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) derives from thyroid C cells, a neuroendocrine cell that produces calcitonin and represents <1% of all thyroid cells ( Leboulleux et al . 2004 , Matias-Guiu et al . 2004 , Hoff & Hoff 2007 ). MTC

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-08-0289
Volume/Issue:
Volume 16: Issue 4
Free access